NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/09/2025
Voltar para busca
Dado oficial do USPTO
GEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
26/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
27/11/2008
Data de registro
02/11/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/10/2021
Última transação
26/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Berlin, DE
Examinador
MORRIS,KRISTINA KLOIBER
Unidade examinadora
M70
Titulares e representantes
Titulares
Glycotope GmbH
Glycotope GmbH
Representantes
Leigh Ann Lindquist SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elementsfragmentsfractions and lysates thereofexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatmentbacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cellsexcept for medical or veterinary purposesfor use in protein productionfood manufacturingscientific researchwaste water treatment; biological preparations for laboratoriesexcept for medical or veterinary purposesfor use in bacterial and cell engineeringcultivationharvestingprotein production; chemical preparations for analysis in laboratoriespreparations for proteinpeptideengineered proteins and peptidesglycoproteinsglycosylationantibody or antigen analysispreparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein productionbacterial and cell engineeringcultivation and harvestingprobes for detecting and analyzing molecules in protein or nucleotide arraysexcept for medical or veterinary purposes; diagnostic preparationsexcept for medical or veterinary purposes; enzymesproteins and respective preparations for industrial purposesengineered proteinsglycosylated proteinsantibodiesenzymes for use in glycosylationenzyme substratesproteins used in the manufacture of cosmeticsbeveragesfood products and food supplements; ferments for chemical purposesyeastbacteriummoldenzymethat causes fermentation; in-vitro diagnosticsother than for medical purposes; carbohydrates for use in the manufacture of food and nutraceuticals; cultures of microorganisms and cells and elementsfragmentsfractions and lysates thereofother than for medical or veterinary purposescultures of microorganisms and cells other than for medical and veterinary usemicroorganism or cell cultures for use in protein productionfood manufacturingscientific researchwaste water treatmentcultures of microorganisms or cells for use in expression of glycosylated proteins and peptides; expression systems for proteins and peptides comprising cellsparticularly human cells and microorganisms suitable for expressing engineered or glycosylated proteins or peptidescapable of providing optimized glycosylation; milk ferments for medical research purposes
Classe 5
Pharmaceutical and veterinary preparations for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic foods adapted for medical use; food for babies; medical plasters; materials for medical dressings; materials for dental filling and impression materials for dental purposes; disinfectants for sanitary purposes; preparations for destroying vermin; fungicidesherbicides; adjuvants for medical purposes; Medicines for human and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymeproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicineas nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; carbohydrates for medical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; cultures of human cells for medical or veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; medical drinks for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; microorganismscells and preparations containing elementsfragmentsfractions and lysates of microorganisms or cells for medical and veterinary purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; biological therapeuticstherapeutics containing cellsmicroorganismsproteinsglycoproteinspeptidesglycopeptides or modified or conjugated versions thereof ; milk ferments for pharmaceutical purposes for prophylaxis or treatment of cancerinflammatory diseasesautoimmune diseasesallergiescardiovascular diseasesinfectious diseasesneurological diseasesgastrointestinal diseasesfor use in wound healingformation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposesenzymesproteinsantibodiescellsmicroorganisms as well as fragmentsfractionselements and lysates thereof as nutritional additives; sugar and carbohydrates for medical purposestherapeutically and prophylactically active sugar and carbohydratesdietetic sugar and carbohydratessugar and carbohydrate replacements
Classe 42
Scientific and technological services and research and designer services relating theretoscientific researchscientific analysistechnology consultation and researchproduct development and optimization in the field of biotechnologyprotein productionglycosylationoptimization of proteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; industrial analysis and research services in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveysconducting biotechnology surveyspharmacology surveys; conducting scientific surveys in the field of biotechnologybacterial and cell engineeringprotein productionglycosylation; research and development in the field of bacteriologycytologyantibody technologychemistryimmunologycosmetics of expression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesparticularly for proteins and peptides; quality control; research and development of new products and technologies in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting for others; technology and scientific consultancy in the field of biotechnologyprotein productionglycosylationproteinantibody and enzyme activitybacteria and cell engineeringcultivation and harvesting; research and development in the field of glycomicsexpression systems in the nature of glycosylation of proteinspeptidesantibodies and enzymesdevelopment and improvement of cellscell lines and microorganismsantibody-engineeringoptimised biological therapeuticsnutraceuticalsfood and nutritional supplements; researchquality controltechnology consultancy and product development in the field of proteinsantibodiesmicroorganisms and cells; research and development in the field of microorganisms and cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
02/10/2022
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
23/08/2022
INPC
INVALIDATION PROCESSED
23/08/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
30/06/2022
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
30/10/2021
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
30/10/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
28/10/2021
PR71
POST REGISTRATION ACTION MAILED - SEC.71
06/05/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/01/2021
ES71
TEAS SECTION 71 RECEIVED
02/11/2020
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
08/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/12/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/11/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
13/12/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/10/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/06/2018
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
30/03/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/11/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
20/10/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
23/06/2017
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
23/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/06/2017
ES75
TEAS SECTION 71 & 15 RECEIVED
27/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/12/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2011
FIMP
FINAL DISPOSITION PROCESSED
11/02/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/08/2010
PUBO
PUBLISHED FOR OPPOSITION
17/08/2010
CNEA
EXAMINERS AMENDMENT MAILED
16/07/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/07/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/07/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/07/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
15/07/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/07/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
15/07/2010
CNEA
EXAMINERS AMENDMENT MAILED
15/07/2010
CNFR
FINAL REFUSAL MAILED
20/01/2010
CNFR
FINAL REFUSAL WRITTEN
19/01/2010
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/01/2010
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
31/12/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/12/2009
ALIE
ASSIGNED TO LIE
28/12/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2009
RFNT
REFUSAL PROCESSED BY IB
10/07/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/06/2009
RFRR
REFUSAL PROCESSED BY MPU
15/06/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/06/2009
CNRT
NON-FINAL ACTION WRITTEN
12/06/2009
MAFR
APPLICATION FILING RECEIPT MAILED
09/06/2009
DOCK
ASSIGNED TO EXAMINER
05/06/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.